Financial reports
10-K
2023 FY
Annual report
18 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
7 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
29 Mar 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Apr 24
8-K
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results
18 Mar 24
8-K
Departure of Directors or Certain Officers
11 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
7 Mar 24
8-K
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
22 Feb 24
8-K
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
21 Feb 24
8-K
Other Events
22 Jan 24
8-K
Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering
22 Dec 23
8-K
Entry into a Material Definitive Agreement
28 Nov 23
8-K
Other Events
27 Nov 23
Registration and prospectus
25-NSE
Exchange delisting
25 Apr 24
424B3
Prospectus supplement
2 Apr 24
S-3
Shelf registration
22 Mar 24
424B4
Prospectus supplement with pricing info
20 Dec 23
S-1/A
IPO registration (amended)
14 Dec 23
S-1/A
IPO registration (amended)
11 Dec 23
S-1/A
IPO registration (amended)
30 Nov 23
S-1
IPO registration
20 Oct 23
424B3
Prospectus supplement
9 Jun 23
S-3
Shelf registration
1 Jun 23
Proxies
DEFA14A
Additional proxy soliciting materials
16 Feb 24
DEF 14A
Definitive proxy
24 Jan 24
PRE 14A
Preliminary proxy
12 Jan 24
DEFA14A
Additional proxy soliciting materials
7 Sep 23
DEFA14A
Additional proxy soliciting materials
7 Aug 23
DEF 14A
Definitive proxy
7 Aug 23
PRE 14A
Preliminary proxy
28 Jul 23
DEFA14A
Additional proxy soliciting materials
23 May 22
DEF 14A
Definitive proxy
20 May 22
PRE 14A
Preliminary proxy
5 May 22
Other
EFFECT
Notice of effectiveness
3 Apr 24
EFFECT
Notice of effectiveness
19 Dec 23
CORRESP
Correspondence with SEC
18 Dec 23
CORRESP
Correspondence with SEC
18 Dec 23
CORRESP
Correspondence with SEC
11 Dec 23
UPLOAD
Letter from SEC
6 Dec 23
EFFECT
Notice of effectiveness
12 Jun 23
CORRESP
Correspondence with SEC
7 Jun 23
UPLOAD
Letter from SEC
7 Jun 23
EFFECT
Notice of effectiveness
29 Mar 21
Ownership
4
Scott Durbin
13 Mar 24
4
Sonja Nelson
13 Mar 24
4
Gary J Pruden
13 Mar 24
4
Timothy P. Moran
12 Mar 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
3
Initial statement of insider ownership
22 Sep 23
SC 13G
Orchestra BioMed Holdings, Inc.
22 Sep 23
4
Scott Durbin
6 Sep 23
3
Scott Durbin
6 Sep 23
3
Ravit Ram
21 Jun 23